Neutral-Atom Platform Technologies vs Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Side-by-side comparison of two grants.
| Attribute | Neutral-Atom Platform Technologies | Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | $23.1M | $9.1M |
| Deadline | Closes 2026-11-17 | Closes 2026-09-15 |
| Region | EU | EU |
| Sector | Health | Health |
| Funder | European Commission (HORIZON) | European Commission (HORIZON) |
| Who it's for | researchers | researchers |
noindex — no measured search demand